Development Services

Development is the key foundation of our service

Our objective is to develop smart, efficient, cost-effective, and sustainable processes that enable our clients to treat disease more rapidly and benefit patients worldwide. Our services efficiently and effectively enable our clients to progress through pre-clinical and into the clinical phases to register, validate, and ultimately commercialize their NCEs.

Our scientists, supported by dedicated project managers, ensure the provision of our multi-faceted services in a compliant and timely manner; incorporating process development and optimization while anticipating scale-up issues with a systematic approach including Quality by Design methods and the effective use of formal risk management processes to define and steer the product control strategy.

Our Expertise

There are very few chemistry challenges we have not experienced at some point, and our expertise includes:

  • Route scouting to identify the best route to fulfill Customer expectations
  • Vast experience in multi-step synthesis for simple and complex molecules
  • Process development and optimization for Intermediates and APIs from grams to hundreds of Kilo scale
  • Delivery of safe, robust, economic, and optimized processes leveraging several Kilolabs and pilot plant reactors from 5L to 6000L
  • Crystallization development and optimization
  • Synthesis and Regulatory Support for APIs from Phase I to Phase III clinical trials
  • Strict compliance with any quality and regulatory requirements
  • Efficient and environment-friendly processes
Dr. Ravikesh Yadav – General Manager - R&D DCAL India

“With a Motivational and extremely supportive management, we have access to the latest technologies and Chemistry, whereby we can work on new products and improved processes, contributing to Company’s mission to 'save lives' with quality drugs for all humans.”
Dr. Ravikesh Yadav – General Manager - R&D DCAL India

Company Profile

CONTACT US TODAY OR DOWNLOAD
OUR COMPANY PROFILE BROCHURE
FOR FURTHER INFORMATION

SUBSCRIBE TO OUR MAILING LIST FOR THE LATEST NEWS UPDATES